This topic contains a solution. Click here to go to the answer

Author Question: How does a transient ischemic attack (TIA) differ from a cerebrovascular accident (CVA)? a. A TIA ... (Read 99 times)

soccerdreamer_17

  • Hero Member
  • *****
  • Posts: 552
How does a transient ischemic attack (TIA) differ from a cerebrovascular accident (CVA)?
 a. A TIA may be hemorrhagic.
  b. A CVA is not caused by ischemia.
  c. A CVA is symptomatic for more than 24 hours.
  d. A TIA results from an aneurysm.

Question 2

What does the prognosis of a disease refer to?
 a. the mortality rates of the disease
 b. the degree of infectiousness
 c. the ability for the disease to spread
  d. the expected or usual outcome
 e. the cause of the disease



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Mollythedog

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

c

Answer to Question 2

d





 

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library